Survival RateDisease-Free SurvivalSurvival AnalysisCell SurvivalTreatment OutcomePrognosisKaplan-Meier EstimateRetrospective StudiesSurvivalNeoplasm StagingAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyFollow-Up StudiesGraft SurvivalNeoplasm Recurrence, LocalProportional Hazards ModelsTime FactorsChemotherapy, AdjuvantTumor Markers, BiologicalLung NeoplasmsMultivariate AnalysisAntineoplastic AgentsBreast NeoplasmsAdenocarcinomaNeoplasm MetastasisCisplatinFluorouracilLymphatic MetastasisLiver NeoplasmsVincristineCyclophosphamideDisease ProgressionDoxorubicinImmunohistochemistryDrug Administration ScheduleRadiotherapy, AdjuvantProspective StudiesRemission InductionCarcinoma, Squamous CellCarcinoma, Non-Small-Cell LungRecurrenceColorectal NeoplasmsBrain NeoplasmsRisk FactorsDeoxycytidinePrednisoneNeoadjuvant TherapyCohort StudiesCarcinoma, HepatocellularSalvage TherapyPredictive Value of TestsStomach NeoplasmsEtoposideRadiotherapy DosageCarcinomaAge FactorsOvarian NeoplasmsApoptosisActuarial AnalysisChemoradiotherapyNeoplasm InvasivenessPancreatic NeoplasmsTransplantation, HomologousAntimetabolites, AntineoplasticRisk AssessmentGene Expression Regulation, NeoplasticCell Line, TumorOrganoplatinum CompoundsEsophageal NeoplasmsAntibodies, Monoclonal, HumanizedCarboplatinTransplantation, AutologousVinblastinePaclitaxelLeucovorinTaxoidsDacarbazineBone NeoplasmsRadiotherapyLife TablesMelanomaNeoplasm GradingHepatectomyMultiple MyelomaDose FractionationHead and Neck NeoplasmsRegistriesMethotrexateHematopoietic Stem Cell TransplantationSarcomaLeukemia, Myeloid, AcuteLymph Node ExcisionKidney NeoplasmsCytarabineGlioblastomaLymphoma, Large B-Cell, DiffuseLiver TransplantationAntibodies, MonoclonalRandomized Controlled Trials as TopicLymphoma, Non-Hodgkin